Loading organizations...
HelloSelf is a technology company.
HelloSelf has raised $27.7M across 2 funding rounds.
HelloSelf has raised $27.7M in total across 2 funding rounds.
At HelloSelf, we create the environments and establish the best conditions for therapists and members to connect, fostering a relationship and unlocking their potential.
HelloSelf is a London-based BrainTech company offering a digital platform for personalized online mental health therapy. It connects users with vetted clinical psychologists and CBT therapists via encrypted video sessions, powered by AI matching tools, session summaries, progress trackers, and an AI therapeutic assistant for insights and check-ins between sessions[1][2][3][6]. Serving individuals, families, employers (e.g., Fox Williams, BGF), insurers (e.g., Bupa, AXA), and the NHS, it addresses access barriers to mental healthcare, delivering evidence-based therapy with an 82% success rate and supporting nearly 1,000 active members weekly[1][5][6]. Growth includes a 2023 $20M Series B led by Octopus Ventures, TechNation Upscale selection, and an NHS pilot partnership[1][4].
Founded in 2018 by Charlie Wells (also CEO), HelloSelf emerged from his personal survival of a rare, often fatal brain hemorrhage, inspiring a mission to "make Every Self Better" amid global mental health needs affecting 792 million people[1][2][3]. Soft-launched on January 6, 2019, after nine months of testing pricing, interviewing users and specialists, analyzing competitors, and building wireframes, the initial model combined a subscription AI LifeCoach bot with pay-as-you-go therapist sessions to foster self-awareness and progress tracking[3]. Early traction built through self-referrals, GP/clinician pathways, and employer/insurer programs, culminating in the landmark 2023 NHS partnership—HelloSelf's first public sector deal—as a pivotal endorsement[1].
HelloSelf rides the surging demand for digital mental health solutions amid rising global prevalence (792M affected) and strained public systems like the UK's NHS, where access delays persist[1][2][3]. Timing aligns with post-pandemic telehealth acceleration, AI advancements in healthcare, and BrainTech/neuroscience integration for personalized care—positioned as a "platform" connecting providers/patients without direct employment, enabling scalability[3][4][6]. Market forces favoring it include employer wellness mandates, insurer adoption, and public sector pilots, influencing the ecosystem by validating AI-enhanced therapy (e.g., via TechNation recognition) and bridging private/public gaps to improve outcomes[1][4].
HelloSelf's NHS expansion, $20M funding, and AI refinements position it for rapid scaling into public health infrastructure and international markets, potentially dominating employer/insurer segments with sustained 82% efficacy[1][4][5]. Trends like AI-driven personalization and hybrid therapy models will propel growth, evolving its influence from startup innovator to ecosystem shaper—helping more "selves" thrive sooner, true to Wells' vision sparked by his own recovery[1][2][3].
HelloSelf has raised $27.7M in total across 2 funding rounds.
HelloSelf's investors include Octopus Ventures, Alex Stephany, Errol Damelin, Ian Hogarth, Manta Ray Ventures, OMERS, Harry Briggs, 2Enable Partners.
HelloSelf has raised $27.7M across 2 funding rounds. Most recently, it raised $20.0M Series B in March 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2023 | $20.0M Series B | Octopus Ventures | Alex Stephany, Errol Damelin, Ian Hogarth, Manta Ray Ventures, OMERS |
| Mar 12, 2021 | $7.7M Series A | Harry Briggs | 2Enable Partners, Manta Ray Ventures |